{"DataElement":{"publicId":"4118271","version":"1","preferredName":"Breast Carcinoma Surgical Involvement Type","preferredDefinition":"The information related to the type of breast carcinoma margin involvement","longName":"3290705v1.0:4118196v1.0","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3290705","version":"1","preferredName":"Breast Carcinoma Surgical Procedure Margin Histology","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002_A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Margin; the boundary line or the area immediately inside the boundary._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"2624028v1.0:3290703v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2624028","version":"1","preferredName":"Breast Carcinoma Surgical Procedure","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which \"transplantation\" is used.","longName":"C4872:C15329","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D3BD108-A847-3B9E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-03","endDate":null,"createdBy":"DWARZEL","dateCreated":"2007-04-03","modifiedBy":"ONEDATA","dateModified":"2007-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3290703","version":"1","preferredName":"Margin Histology","preferredDefinition":"Margin; the boundary line or the area immediately inside the boundary.:The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C25563:C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin","conceptCode":"C25563","definition":"A boundary line or the area immediately inside the boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9DD9-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"ONEDATA","dateModified":"2011-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9DEA-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4118196","version":"1","preferredName":"Breast Carcinoma Involvement Type","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla._To have a connection by participation or association or use; sharing in an activity or process._Something distinguishable as an identifiable class based on common qualities.","longName":"4118196v1.0","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2991873","version":"1","preferredName":"Other","longName":"2991873","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC8B94A-9F2D-1457-E040-BB89AD430D33","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  WZhang, 02/23/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BC25B-A922-EBB3-E040-BB89AD435729","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ (DCIS) and Lobular carcinoma in situ (LCIS)","valueDescription":"Ductal carcinoma in situ (DCIS) and Lobular carcinoma in situ (LCIS)","ValueMeaning":{"publicId":"4118197","version":"1","preferredName":"Ductal carcinoma in situ (DCIS) and Lobular carcinoma in situ (LCIS)","longName":"4118197","preferredDefinition":"Ductal carcinoma in situ (DCIS) and Lobular carcinoma in situ (LCIS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BC25B-A92C-EBB3-E040-BB89AD435729","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BC25B-A945-EBB3-E040-BB89AD435729","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Lobular carcinoma in situ (LCIS)","valueDescription":"Lobular carcinoma in situ (LCIS)","ValueMeaning":{"publicId":"4118198","version":"1","preferredName":"Lobular carcinoma in situ (LCIS)","longName":"4118198","preferredDefinition":"Lobular carcinoma in situ (LCIS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BC25B-A94F-EBB3-E040-BB89AD435729","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BC25B-A968-EBB3-E040-BB89AD435729","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ (DCIS)","valueDescription":"Ductal carcinoma in situ (DCIS)","ValueMeaning":{"publicId":"4118199","version":"1","preferredName":"Ductal carcinoma in situ (DCIS)","longName":"4118199","preferredDefinition":"Ductal carcinoma in situ (DCIS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BC25B-A972-EBB3-E040-BB89AD435729","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BC25B-A98B-EBB3-E040-BB89AD435729","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Invasive tumor","valueDescription":"Invasive tumor","ValueMeaning":{"publicId":"2567282","version":"1","preferredName":"Invasive tumor","longName":"2567282","preferredDefinition":"Invasive tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3DF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"ONEDATA","dateModified":"2003-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BC25B-A99F-EBB3-E040-BB89AD435729","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4118195","version":"1","preferredName":"Breast Carcinoma Involvement Type","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.:To have a connection by participation or association or use; sharing in an activity or process.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4872:C25548:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BC25B-A8FD-EBB3-E040-BB89AD435729","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BC25B-A90E-EBB3-E040-BB89AD435729","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"BRETTS","dateModified":"2015-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"If yes, specify","type":"Preferred Question Text","description":"If yes, specify","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BEF55-0E91-99E0-E040-BB89AD432543","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2014-01-28","modifiedBy":"BRETTS","dateModified":"2015-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}